CoChat

Screening for Gestational Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Open access
Pillay, Jennifer, Donovan, Lois, Guitard, Samantha, Zakher, Bernadette, Gates, Michelle, Gates, Allison, Vandermeer, Ben, Bougatsos, Christina, Chou, Roger, Hartling, Lisa · 2021 · JAMA
Cited by 99

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Importance: Gestational diabetes is associated with several poor health outcomes. Objective: To update the 2012 review on screening for gestational diabetes to inform the US Preventive Services Task Force. Data Sources: MEDLINE, EMBASE, and CINAHL (2010 to May 2020), ClinicalTrials.gov, reference lists; surveillance through June 2021. Study Selection: English-language intervention studies for screening and treatment; observational studies on screening; prospective studies on screening test accuracy. Data Extraction and Synthesis: Dual review of titles/abstracts, full-text articles, and study quality. Single-reviewer data abstraction with verification. Random-effects meta-analysis or bivariate analysis (accuracy). Main Outcomes and Measures: Pregnancy, fetal/neonatal, and long-term health outcomes; harms of screening; accuracy. Results: A total of 76 studies were included (18 randomized clinical trials [RCTs] [n = 31 241], 2 nonrandomized intervention studies [n = 190], 56 observational studies [n = 261 678]). Direct evidence on benefits of screening vs no screening was limited to 4 observational studies with inconsistent findings and methodological limitations. Screening was not significantly associated with serious or long-term harm. In 5 RCTs (n = 25 772), 1-step (International Association of Diabetes and Pregnancy Study Group) vs 2-step (Carpenter and Coustan) screening was significantly associated with increased likelihood of gestational diabetes (11.5% vs 4.9%) but no improved health outcomes. At or after 24 weeks of gestation, oral glucose challenge tests with 140- and 135-mg/dL cutoffs had sensitivities of 82% and 93%, respectively, and specificities of 82% and 79%, respectively, against Carpenter and Coustan criteria, and a test with a 140-mg/dL cutoff had sensitivity of 85% and specificity of 81% against the National Diabetes Group Data criteria. Fasting plasma glucose tests with cutoffs of 85 and 90 mg/dL had sensitivities of 88% and 81% and specificities of 73% and 82%, respectively, against Carpenter and Coustan criteria. Based on 8 RCTs and 1 nonrandomized study (n = 3982), treatment was significantly associated with decreased risk of primary cesarean deliveries (relative risk [RR], 0.70 [95% CI, 0.54-0.91]; absolute risk difference [ARD], 5.3%), shoulder dystocia (RR, 0.42 [95% CI, 0.23-0.77]; ARD, 1.3%), macrosomia (RR, 0.53 [95% CI, 0.41-0.68]; ARD, 8.9%), large for gestational age (RR, 0.56 [95% CI, 0.47-0.66]; ARD, 8.4%), birth injuries (odds ratio, 0.33 [95% CI, 0.11-0.99]; ARD, 0.2%), and neonatal intensive care unit admissions (RR, 0.73 [95% CI, 0.53-0.99]; ARD, 2.0%). The association with reduction in preterm deliveries was not significant (RR, 0.75 [95% CI, 0.56-1.01]). Conclusions and Relevance: Direct evidence on screening vs no screening remains limited. One- vs 2-step screening was not significantly associated with improved health outcomes. At or after 24 weeks of gestation, treatment of gestational diabetes was significantly associated with improved health outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2021.10404

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 80

  1. American College of Obstetricians and Gynecologists, 2018, ACOG Practice Bulletin No. 190 summary: gestational diabetes mellitus., Obstet Gynecol, 131, 406, 10.1097/AOG.0000000000002498 · DOI
  2. Casagrande, 2018, Prevalence of gestational diabetes and subsequent type 2 diabetes among U.S. women., Diabetes Res Clin Pract, 141, 200, 10.1016/j.diabres.2018.05.010 · DOI · Paper page
  3. Lavery, 2017, Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010., BJOG, 124, 804, 10.1111/1471-0528.14236 · DOI · Paper page
  4. Zhou, 2018, Prevalence and trends in gestational diabetes mellitus among women in the US, 2006-2016., Diabetes., 67, 10.2337/db18-121-OR · DOI
  5. Basri, 2018, The World Health Organization (WHO) versus the International Association of Diabetes and Pregnancy Study Group (IADPSG) diagnostic criteria of gestational diabetes mellitus (GDM) and their associated maternal and neonatal outcomes., Horm Mol Biol Clin Investig, 34
  6. Khalifeh, 2020, One-step versus two-step diagnostic testing for gestational diabetes: a randomized controlled trial., J Matern Fetal Neonatal Med, 33, 612, 10.1080/14767058.2018.1498480 · DOI
  7. Scifres, 2015, Gestational diabetes diagnostic methods (GD2M) pilot randomized trial., Matern Child Health J, 19, 1472, 10.1007/s10995-014-1651-4 · DOI
  8. Sevket, 2014, To evaluate the prevalence and clinical outcomes using a one-step method versus a two-step method to screen gestational diabetes mellitus., J Matern Fetal Neonatal Med, 27, 36, 10.3109/14767058.2013.799656 · DOI · Paper page
  9. Bevier, 1999, Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia., Am J Perinatol, 16, 269, 10.1055/s-2007-993871 · DOI · Paper page
  10. Bonomo, 2005, Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized clinical trial., Diabet Med, 22, 1536, 10.1111/dme.2005.22.issue-11 · doi:10.1111/dme.2005.22.issue-11
  11. Fadl, 2015, Randomized controlled study in pregnancy on treatment of marked hyperglycemia that is short of overt diabetes., Acta Obstet Gynecol Scand, 94, 1181, 10.1111/aogs.2015.94.issue-11 · doi:10.1111/aogs.2015.94.issue-11
  12. Hughes, 2018, Prediabetes in pregnancy, can early intervention improve outcomes? a feasibility study for a parallel randomised clinical trial., BMJ Open, 8, 10.1136/bmjopen-2017-018493 · DOI
  13. Kokanali, 2014, The effect of treatment on pregnancy outcomes in women with one elevated oral glucose tolerance test value., Ginekol Pol, 85, 748
  14. Osmundson, 2016, Early screening and treatment of women with prediabetes: a randomized controlled trial., Am J Perinatol, 33, 172
  15. Simmons, 2018, The Treatment Of Booking Gestational Diabetes Mellitus (TOBOGM) pilot randomised controlled trial., BMC Pregnancy Childbirth, 18, 151, 10.1186/s12884-018-1809-y · DOI · Paper page
  16. Yang, 2014, A randomised translational trial of lifestyle intervention using a 3-tier shared care approach on pregnancy outcomes in Chinese women with gestational diabetes mellitus but without diabetes., J Transl Med, 12, 290, 10.1186/s12967-014-0290-2 · DOI · Paper page
  17. Deveer, 2013, The effect of diet on pregnancy outcomes among pregnant with abnormal glucose challenge test., Eur Rev Med Pharmacol Sci, 17, 1258
  18. Vinter, 2018, Lifestyle intervention in Danish obese pregnant women with early gestational diabetes mellitus according to WHO 2013 criteria does not change pregnancy outcomes: results from the LiP (Lifestyle in Pregnancy) study., Diabetes Care, 41, 2079, 10.2337/dc18-0808 · DOI · Paper page
  19. Chanprapaph, 2004, Prevalence of gestational diabetes mellitus (GDM) in women screened by glucose challenge test (GCT) at Maharaj Nakorn Chiang Mai Hospital., J Med Assoc Thai, 87, 1141
  20. Hivert, 2012, Impact of the creation of a specialized clinic for prenatal blood sampling and follow-up care in pregnant women., J Obstet Gynaecol Can, 34, 236, 10.1016/S1701-2163(16)35194-5 · DOI
  21. Solomon, 1996, Variability in diagnostic evaluation and criteria for gestational diabetes., Diabetes Care, 19, 12, 10.2337/diacare.19.1.12 · DOI · Paper page
  22. Stacey, 2019, Gestational diabetes and the risk of late stillbirth: a case-control study from England, UK., BJOG, 126, 973, 10.1111/1471-0528.15659 · DOI · Paper page
  23. Daniells, 2003, Gestational diabetes mellitus: is a diagnosis associated with an increase in maternal anxiety and stress in the short and intermediate term?, Diabetes Care, 26, 385, 10.2337/diacare.26.2.385 · DOI
  24. Doughty, 2018, Barriers to exclusive breastfeeding among women with gestational diabetes mellitus in the United States., J Obstet Gynecol Neonatal Nurs, 47, 301, 10.1016/j.jogn.2018.02.005 · DOI
  25. Kerbel, 1997, Adverse effects of screening for gestational diabetes: a prospective cohort study in Toronto, Canada., J Med Screen, 4, 128, 10.1177/096914139700400303 · DOI
  26. Loewenberg Weisband, 2017, Hospital supplementation differentially impacts the association between breastfeeding intention and duration among women with and without gestational diabetes mellitus history., Breastfeed Med, 12, 338, 10.1089/bfm.2017.0019 · DOI
  27. Oza-Frank, 2017, In-hospital breastfeeding experiences among women with gestational diabetes., Breastfeed Med, 12, 261, 10.1089/bfm.2016.0197 · DOI
  28. Rumbold, 2002, Women’s experiences of being screened for gestational diabetes mellitus., Aust N Z J Obstet Gynaecol, 42, 131, 10.1111/ajo.2002.42.issue-2 · doi:10.1111/ajo.2002.42.issue-2
  29. Agarwal, 2006, Gestational diabetes: utility of fasting plasma glucose as a screening test depends on the diagnostic criteria., Diabet Med, 23, 1319, 10.1111/dme.2006.23.issue-12 · doi:10.1111/dme.2006.23.issue-12
  30. Agarwal, 2000, Fasting plasma glucose as a screening test for gestational diabetes in a multi-ethnic, high-risk population., Diabet Med, 17, 720, 10.1046/j.1464-5491.2000.00371.x · DOI
  31. Agarwal, 2001, Gestational diabetes screening of a multiethnic, high-risk population using glycated proteins., Diabetes Res Clin Pract, 51, 67, 10.1016/S0168-8227(00)00206-0 · DOI
  32. Agarwal, 2018, Gestational diabetes mellitus: using the fasting plasma glucose level to simplify the International Association of Diabetes and Pregnancy Study Groups diagnostic algorithm in an adult South Asian population., Can J Diabetes, 42, 500, 10.1016/j.jcjd.2017.12.009 · DOI
  33. Ayach, 2006, Comparison between 100-g glucose tolerance test and two other screening tests for gestational diabetes: combined fasting glucose with risk factors and 50-g glucose tolerance test., Sao Paulo Med J, 124, 4, 10.1590/S1516-31802006000100002 · DOI
  34. Benaiges, 2017, Is first-trimester HbA1c useful in the diagnosis of gestational diabetes?, Diabetes Res Clin Pract, 133, 85, 10.1016/j.diabres.2017.08.019 · DOI
  35. Benhalima, 2018, A modified two-step screening strategy for gestational diabetes mellitus based on the 2013 WHO criteria by combining the glucose challenge test and clinical risk factors., J Clin Med, 7, 13, 10.3390/jcm7100351 · DOI
  36. Bhavadharini, 2017, Elevated glycated hemoglobin predicts macrosomia among Asian Indian pregnant women (WINGS-9)., Indian J Endocrinol Metab, 21, 184, 10.4103/2230-8210.196003 · DOI
  37. Braga, 2019, Relationship between inflammatory markers, glycated hemoglobin and placental weight on fetal outcomes in women with gestational diabetes., Arch Endocrinol Metab, 63, 22, 10.20945/2359-3997000000099 · DOI
  38. Cetin, 1997, Time-dependent gestational diabetes screening values., Int J Gynaecol Obstet, 56, 257, 10.1016/S0020-7292(96)02831-7 · DOI
  39. Chevalier, 2011, Universal two-step screening strategy for gestational diabetes has weak relevance in French Mediterranean women: should we simplify the screening strategy for gestational diabetes in France?, Diabetes Metab, 37, 419, 10.1016/j.diabet.2011.01.004 · DOI
  40. Espinosa de los Monteros, 1999, The after breakfast 50-g, 1-hour glucose challenge test in urban Mexican pregnant women: its sensitivity and specificity evaluated by three diagnostic criteria for gestational diabetes mellitus., Acta Obstet Gynecol Scand, 78, 294, 10.1034/j.1600-0412.1999.780404.x · DOI
  41. Dickson, 2019, Fasting plasma glucose and risk factor assessment: comparing sensitivity and specificity in identifying gestational diabetes in urban black African women., S Afr Med J, 110, 21, 10.7196/SAMJ.2019.v110i1.14089 · DOI
  42. Göbl, 2012, A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus., Diabetologia, 55, 3173, 10.1007/s00125-012-2726-7 · DOI
  43. Kauffman, 2006, Detection of gestational diabetes mellitus by homeostatic indices of insulin sensitivity: a preliminary study., Am J Obstet Gynecol, 194, 1576, 10.1016/j.ajog.2006.01.010 · DOI
  44. Lamar, 1999, Jelly beans as an alternative to a fifty-gram glucose beverage for gestational diabetes screening., Am J Obstet Gynecol, 181, 1154, 10.1016/S0002-9378(99)70099-2 · DOI
  45. Lekva, 2018, Prediction of gestational diabetes mellitus and pre-diabetes 5 years postpartum using 75-g oral glucose tolerance test at 14-16 weeks’ gestation., Sci Rep, 8, 13392, 10.1038/s41598-018-31614-z · DOI
  46. Navid, 2014, Glucose challenge test—is it an effective screening tool for gestational diabetes mellitus in low risk population?, RMJ., 39, 428
  47. Odsæter, 2016, Hemoglobin A1c as screening for gestational diabetes mellitus in Nordic Caucasian women., Diabetol Metab Syndr, 8, 43, 10.1186/s13098-016-0168-y · DOI
  48. Olagbuji, 2017, Accuracy of 50-g glucose challenge test to detect International Association of Diabetes and Pregnancy Study Groups criteria–defined hyperglycemia., Int J Gynaecol Obstet, 139, 312, 10.1002/ijgo.2017.139.issue-3 · doi:10.1002/ijgo.2017.139.issue-3
  49. Perea-Carrasco, 2002, A simple index for detection of gestational diabetes mellitus., J R Soc Med, 95, 435, 10.1177/014107680209500903 · doi:10.1177/014107680209500903
  50. Perucchini, 1999, Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study., BMJ, 319, 812, 10.1136/bmj.319.7213.812 · DOI · Paper page
  51. Pezeshki, 2019, Early screening of gestational diabetes mellitus using hemoglobin A1c: revising current screening guidelines., Caspian J Intern Med, 10, 16
  52. Poo, 2019, Optimal first trimester HbA1c threshold to identify Singaporean women at risk of gestational diabetes mellitus and adverse pregnancy outcomes: a pilot study., Obstet Med, 12, 79, 10.1177/1753495X18795984 · DOI
  53. Poomalar, 2013, A comparison of fasting plasma glucose and glucose challenge test for screening of gestational diabetes mellitus., J Obstet Gynaecol, 33, 447, 10.3109/01443615.2013.771156 · DOI
  54. Rajput, 2012, Utility of HbA1c for diagnosis of gestational diabetes mellitus., Diabetes Res Clin Pract, 98, 104, 10.1016/j.diabres.2012.02.018 · DOI
  55. Saadati, 2016, Determination of relationship between HbA1c levels and early diagnosis of gestational diabetes., Int J Pharm Res All Sci., 5, 252
  56. Sacks, 2003, Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes., Obstet Gynecol, 101, 1197
  57. Saeedi, 2018, Characteristics of different risk factors and fasting plasma glucose for identifying GDM when using IADPSG criteria: a cross-sectional study., BMC Pregnancy Childbirth, 18, 225, 10.1186/s12884-018-1875-1 · DOI
  58. Sermer, 1998, The Toronto Tri-Hospital Gestational Diabetes Project: a preliminary review., Diabetes Care, 21, B33
  59. Sevket, 2014, The use of HbA1c as an aid in the diagnosis of gestational diabetes mellitus., J Obstet Gynaecol, 34, 690, 10.3109/01443615.2014.925855 · DOI
  60. Sham, 2014, Comparative study of fasting plasma glucose concentration and glucose challenge test for screening gestational diabetes mellitus., JSAFOG., 6, 75, 10.5005/jp-journals-10006-1275 · doi:10.5005/jp-journals-10006-1275
  61. Sharma, 2018, Predictive value of fasting plasma glucose on first antenatal visit before 20 weeks of gestation to diagnose gestational diabetes mellitus., J Clin Diagn Res., 12, QC01
  62. Siricharoenthai, 2020, Diagnostic accuracy of HbA1c in detecting gestational diabetes mellitus., J Matern Fet Neonat Med., 33, 3497, 10.1080/14767058.2019.1576169 · DOI
  63. Soumya, 2015, HbA1c: a useful screening test for gestational diabetes mellitus., Diabetes Technol Ther, 17, 899, 10.1089/dia.2015.0041 · DOI · Paper page
  64. Trujillo, 2014, Fasting plasma glucose to avoid a full OGTT in the diagnosis of gestational diabetes., Diabetes Res Clin Pract, 105, 322, 10.1016/j.diabres.2014.06.001 · DOI
  65. Uncu, 1995, The comparison of 50 grams glucose challenge test, HbA1c and fructosamine levels in diagnosis of gestational diabetes mellitus., Clin Exp Obstet Gynecol, 22, 230
  66. Veres, 2015, The utility of glycated hemoglobin, determined in the second trimester of pregnancy, in diagnosing gestational diabetes., Rom J Diabetes Nutr Metab Dis., 22, 233, 10.1515/rjdnmd-2015-0029 · DOI
  67. Weerakiet, 2006, Can adiponectin predict gestational diabetes?, Gynecol Endocrinol, 22, 362, 10.1080/09513590600818919 · DOI · Paper page
  68. Wu, 2018, The utility of HbA1c combined with haematocrit for early screening of gestational diabetes mellitus., Diabetol Metab Syndr, 10, 14, 10.1186/s13098-018-0314-9 · DOI
  69. Zhu, 2013, Fasting plasma glucose at 24-28 weeks to screen for gestational diabetes mellitus: new evidence from China., Diabetes Care, 36, 2038, 10.2337/dc12-2465 · DOI · Paper page
  70. Saccone, 2017, One step versus two step approach for gestational diabetes screening: systematic review and meta-analysis of the randomized trials., J Matern Fetal Neonat Med, 1
  71. Casey, 2015, Does maternal body mass index influence treatment effect in women with mild gestational diabetes?, Am J Perinatol, 32, 93
  72. Casey, 2020, Effect of treatment of mild gestational diabetes on long-term maternal outcomes., Am J Perinatol, 37, 475, 10.1055/s-0039-1681058 · DOI
  73. Palatnik, 2015, Timing of treatment initiation for mild gestational diabetes mellitus and perinatal outcomes., Am J Obstet Gynecol, 213, 560.e1, 10.1016/j.ajog.2015.06.022 · DOI · Paper page
  74. Berggren, 2012, Perinatal outcomes in Hispanic and non-Hispanic white women with mild gestational diabetes., Obstet Gynecol, 120, 1099, 10.1097/AOG.0b013e31827049a5 · DOI
  75. Lee, 2020, Undiagnosed type 2 diabetes during pregnancy is associated with increased perinatal mortality: a large population-based cohort study in Ontario, Canada., Diabet Med, 37, 1696, 10.1111/dme.14250 · DOI
  76. Simmons, 2018, Hyperglycaemia in early pregnancy: the Treatment Of Booking Gestational Diabetes Mellitus (TOBOGM) study: a randomised controlled trial., Med J Aust, 209, 405, 10.5694/mja2.2018.209.issue-9 · doi:10.5694/mja2.2018.209.issue-9
  77. Farrar, 2016, Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis., BMJ, 354, i4694, 10.1136/bmj.i4694 · DOI · Paper page
  78. Hartling, 2012, Screening and Diagnosing Gestational Diabetes Mellitus. Evid Rep Technol Assess No. 210
  79. Higgins, 2011, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0
  80. Wells, 2009, The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-analyses.

Cited by

See all 99

Metadata

Authors
Pillay, J., Donovan, L., Guitard, S., Zakher, B., Gates, M., Gates, A., Vandermeer, B., Bougatsos, C., Chou, R., & Hartling, L.
Venue
JAMA
Published
2021-08-10
Volume
326
Issue
6
Pages
539
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W3187616180
Cited by
99
References
27
FWCI
12.53
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening for Gestational Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. https://app.cochat.ai/papers/10.1001/jama.2021.10404
The paper
Pillay, J., Donovan, L., Guitard, S., Zakher, B., Gates, M., Gates, A., Vandermeer, B., Bougatsos, C., Chou, R., & Hartling, L. (2021). Screening for Gestational Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. https://doi.org/10.1001/jama.2021.10404

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.